| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.25 | 0.4 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.3 | 0.09 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.32 | 0.05 |